| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/09/2009 | WO2009084497A1 Methyl-substituted piperidine derivative |
| 07/09/2009 | WO2009084482A1 Composition comprising sesamin component and quercetin glycoside |
| 07/09/2009 | WO2009084232A1 Sugar chain-related gene and use thereof |
| 07/09/2009 | WO2009084200A1 External skin preparation for pimpled skin |
| 07/09/2009 | WO2009057056A3 Use and device to prevent ventilator acquired pneumonia using nitric oxide |
| 07/09/2009 | WO2009048778A3 Laminins, derivatives, and compositions including same and method for their therapeutic use |
| 07/09/2009 | WO2008040002A3 Methods, compositions and articles of manufacture for hif modulating compounds |
| 07/09/2009 | US20090176973 Thrombopoietin mimetics |
| 07/09/2009 | US20090176880 Methods for Culturing Human Lung Mast Cells and Uses Thereof |
| 07/09/2009 | US20090176853 Adamantane derivatives |
| 07/09/2009 | US20090176839 Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 07/09/2009 | US20090176836 3-{[(3-amino-3-benzyltetrahydrofuran-2-yl)oxy]methyl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[(methylsulfonyl)(propyl)amino]benzamide, used for preventing the formation of insoluble amyloid proteins |
| 07/09/2009 | US20090176830 Tartrate salt of isofagomine and methods of use |
| 07/09/2009 | US20090176808 combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176800 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia |
| 07/09/2009 | US20090176799 Phosphodiesterase 4 inhibitors |
| 07/09/2009 | US20090176795 Enhanced delivery of antifungal agents |
| 07/09/2009 | US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis |
| 07/09/2009 | US20090176734 Method For Simulating The Functional Attributes Of Human Milk Oligosaccharides In Formula-Fed Infants |
| 07/09/2009 | US20090176730 N4-acylcytosine nucleosides for treatment of viral infections |
| 07/09/2009 | US20090176276 Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide |
| 07/09/2009 | US20090175937 Misuse Preventative, Controlled Release Formulation |
| 07/09/2009 | US20090175918 Ultra-Passivation of Chromium-Containing Alloy and Methods of Producing Same |
| 07/09/2009 | US20090175888 Methods of treating cancer with an antibody-drug conjugate |
| 07/09/2009 | US20090175867 Single-Chain Multivalent Binding Proteins with Effector Function |
| 07/09/2009 | US20090175845 Methods for identifying compounds that modulate phb domain protein activity and compositions thereof |
| 07/09/2009 | DE60019555C5 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit 2-oxy-benzoxazinonderivate for treatment of obesity |
| 07/09/2009 | CA2710740A1 Antitumor agent |
| 07/09/2009 | CA2710388A1 Treatment of abnormal or excessive scars |
| 07/09/2009 | CA2710387A1 Treatment of fibrotic conditions |
| 07/09/2009 | CA2710380A1 Treatment of fibrotic conditions |
| 07/09/2009 | CA2710379A1 Compositions containing sesamin-class compound(s) and quercetin glycoside(s) |
| 07/09/2009 | CA2710232A1 Treatment of abnormal or excessive scars |
| 07/09/2009 | CA2708627A1 High concentration antibody-containing liquid formulation |
| 07/08/2009 | EP2077326A1 Novel nucleic acid |
| 07/08/2009 | EP2077279A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 07/08/2009 | EP2077271A1 Macrolide derivative |
| 07/08/2009 | EP2077268A1 Process for preparing inhibitors of nucleoside metabolism |
| 07/08/2009 | EP2077266A1 2-pyridinecarboxamide derivative having gk-activating activity |
| 07/08/2009 | EP2077260A1 Amide compound or salt thereof, and biofilm formation inhibitor, biofilm remover and bactericide each using the amide compound or salt thereof |
| 07/08/2009 | EP2077122A1 Therapeutic agents for irritable bowel syndrome |
| 07/08/2009 | EP2077120A2 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 07/08/2009 | EP2077114A1 Pharmaceutical preparation for treating fibromyalgia |
| 07/08/2009 | EP2077111A1 Antidepressant agent |
| 07/08/2009 | EP2076268A1 Purine derivatives for the treatment of cystic diseases |
| 07/08/2009 | EP1948661B1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 07/08/2009 | EP1511740B1 Phenyl-thiophene type vitamin d receptor modulators |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | EP1440962B1 Stabilized compositions of aqueous reduced coenzyme q solution |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1371730B1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/08/2009 | EP1126826B9 Multiparticulate modified release composition of methylphenidate |
| 07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
| 07/08/2009 | CN101474398A Use of inhibitors for the treatment of disorders related to RTK hyperfunction |
| 07/08/2009 | CN100510073C Tryptase inhibitor |
| 07/08/2009 | CN100509858C Cross-linked polysaccharide composition |
| 07/08/2009 | CN100509843C Acid-modified arabinogalactan protein composition |
| 07/08/2009 | CN100509811C Azaindoles |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 07/08/2009 | CN100509804C N-substituted piperidine derivatives as serotonin receptor agents |
| 07/08/2009 | CN100509794C Therapeutic heterocyclic compounds |
| 07/08/2009 | CN100509789C Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 07/08/2009 | CN100509788C Neurotensin active 2,3-diaryl-pyrazolidine derivatives |
| 07/08/2009 | CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/08/2009 | CN100509773C Alpha -amino-n-hydroxy-acetamide derivatives |
| 07/08/2009 | CN100509758C Crystal of triterpene derivative |
| 07/08/2009 | CN100508990C Acrochordon alleviation |
| 07/08/2009 | CN100508988C Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| 07/08/2009 | CN100508980C Compositions for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/07/2009 | US7557210 Antiinflamamtory agents |
| 07/07/2009 | US7557140 e.g. 3-[3-(2,4-Difluoro-phenylsulfamoyl)-phenyl]-N-hydroxy-acrylamide; histone deacetylase inhibitor; anticarcinogenic, antiinflammatory agent, autoimmune diseases; leukemia, atheriosclerosis, Alzheimer's disease, rheumatoid arthritis, psoriasis |
| 07/07/2009 | US7557139 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 07/07/2009 | US7557125 Fab I inhibitors |
| 07/07/2009 | US7557118 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one's and analogues, optionally mixed with acceptable carriers, excipients or diluents, used for treating multidrug resistant tumors, for inducing apoptosis and as immunology modulators |
| 07/07/2009 | US7557117 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 07/07/2009 | US7557110 Pyrazolo[1,5-A] pyrimidine derivatives |
| 07/07/2009 | US7557109 Eltoprazine; |
| 07/07/2009 | US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide |
| 07/07/2009 | US7557105 Proliferative disorders; cancer; 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide |
| 07/07/2009 | US7557096 stilbene phosphate derivatives; anticarcinogenic agents; bactericide, fungicide; veterinary medicine |
| 07/07/2009 | US7557083 Gastrokines and derived peptides including inhibitors |
| 07/07/2009 | US7556926 Drug screening; diabetes, obesity, hyperlipemia, arteriosclerosis, hypertension, cardiovascular disorders |
| 07/07/2009 | US7556824 Transdermal patch comprising hydralazine derivative antioxidant and isosorbide di- and/or mononitrate |
| 07/07/2009 | US7556809 Utilizing vascular epithelial growth factor (VEGFR1) polypeptides, fragments and/or encoding oligonucleotides |
| 07/07/2009 | US7556801 Pluripotent somatic stem cells for use in regenerative medicine; use in treatment of vascular disease, Parkinson's disease, diabetes |
| 07/07/2009 | US7556649 Methods and compositions for treating intervertebral disc degeneration |
| 07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/07/2009 | CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 07/07/2009 | CA2450033C Viral polymerase inhibitors |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/07/2009 | CA2405518C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 07/07/2009 | CA2400994C Radioactive therapeutic liposomes |
| 07/07/2009 | CA2378834C Pyrazinones, compositions containing such compounds |
| 07/07/2009 | CA2168029C Prosaposin and cytokine-derived peptides as therapeutic agents |
| 07/02/2009 | WO2009082651A2 Attenuated uracil auxotroph of an apicomplexan and use thereof |
| 07/02/2009 | WO2009082014A1 Drug delivery system |
| 07/02/2009 | WO2009081991A1 Therapeutic agent for cerebral ischemic injury |